CV risk; cardiovascular risk; CV risk factors; cardiovascular risk factors; cardiovascular risk management; CV risk management

A new study calls into question the effectiveness of time-restricted eating (TRE) in producing measurable improvements in metabolic…

NEW ORLEANS — When added to standard lipid-lowering therapy, olezarsen, a drug approved in 2024 for patients with…

Media consumers are bombarded daily with aggressive, testimonial-driven ads for pricey supplements purported to sharpen memory, focus, and…

Older adults taking a combination of medications to treat high blood pressure, cholesterol, and diabetes experienced slower cognitive…

Osteoporosis drug romosozumab showed no increased risk for the development of cardiovascular (CV) events compared with anabolic osteoporosis…